HF
ONCY

HRT Financial’s Oncolytics Biotech ONCY Stock Holding History

HRT Financial’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Buy
126,325
+103,069
+443% +$95.6K ﹤0.01% 3563
2026
Q1 		$19K Buy
23,256
+11,263
+94% +$11.2K ﹤0.01% 3580
2025
Q4 		$10K Sell
11,993
-7,790
-39% -$8.42K ﹤0.01% 3040
2025
Q3 		$27K Buy
+19,783
New +$22.2K ﹤0.01% 2673

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

HRT Financial's ONCY Position: Q2 2026 in Review

HRT Financial increased its Oncolytics Biotech (ONCY) stake by 443% in Q2 2026, buying an estimated $95.6K and bringing the position to 126,325 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #3563.

HRT Financial first reported a position in ONCY in Q3 2025 and has held it in 4 quarters since. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • HRT Financial held 126,325 shares of Oncolytics Biotech worth $119K as of Q2 2026.
  • HRT Financial bought 103,069 Oncolytics Biotech shares in Q2 2026, an estimated $95.6K.
  • Oncolytics Biotech made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3563 holding.
  • HRT Financial first reported a position in Oncolytics Biotech in Q3 2025 and has held it in 4 quarters since.
  • 75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.